EN | 中文

CurePharma is a new start-up company invested by BVCF that mainly focuses on neurodegenerative diseases and nerve injury. The company is developing novel therapeutic approaches based on a revolutionary finding that allows in situ conversion of supportive neural cells into functional neurons. Current R&D activities are carried out for Parkinsons Disease (PD), Retinitis Pigmentosa (RP), stroke, spinal injury, hearing loss. The company also aims at increasing the number of pipelines in the near future.